Trial Details

COMPLETED
Basic Information
Clinical ID c1405
Identifier NCT01461317
Trial Title Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Etrolizumab
Participant Information
Sponsor Genentech, Inc.
City La Jolla
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2011-11-29
Primary Completion Date 2016-08-07
Completion Date 2016-08-07